School- and Home-Based Early Intervention for Toddlers With Autism

NCT ID: NCT00106210

Last Updated: 2013-07-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-05-31

Study Completion Date

2007-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will determine the impact of early intervention on the communication and social development of toddlers with autism.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Autism is a condition that affects brain development, often leading to difficulties in social, emotional, and educational functioning. This study will determine whether early intervention can improve such functioning in toddlers with autism.

Each treatment session will last 6 months. Children with an autism spectrum disorder will be enrolled in one of two parallel classes and will receive one of two treatments 4 days a week for the duration of the session. Children in each class will receive the same amount and level of intervention, but with a different goal focus. Treatments will be school- and home-based; parents will receive instruction on administering the at-home part of the treatment. The intervention will include environmental engineering, developmental approaches, adaptations of traditional behavioral approaches, and contemporary behavioral approaches that apply principles of applied behavior analysis in more naturalistic teaching frameworks. A series of measures including scales, interviews, and observations will be used to assess the children at baseline, study completion, and 6 months after study completion. The children will be videotaped during the school-based intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autistic Disorder Autism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Behavioral Intervention (experimental)

Group Type EXPERIMENTAL

Early intervention blending several tx approaches, w/ focus

Intervention Type BEHAVIORAL

Early intervention blending several different treatment approaches, with a focus on certain skills

2

Behavioral Intervention 2

Group Type ACTIVE_COMPARATOR

Early intervention blending several treatment approaches

Intervention Type BEHAVIORAL

Early intervention blending several different treatment approaches

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Early intervention blending several tx approaches, w/ focus

Early intervention blending several different treatment approaches, with a focus on certain skills

Intervention Type BEHAVIORAL

Early intervention blending several treatment approaches

Early intervention blending several different treatment approaches

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of autism spectrum disorder
* Parent or guardian willing to give informed consent for child's participation
* Developmental level above 9 months on the Visual Reception Scale of the Mullen Scales of Early Learning and on the Adaptive Behavior Composite of the Vineland Adaptive Behavior Scales
* English is primary language for child and family

Exclusion Criteria

* Evidence of vision or hearing impairment
* Diagnosis of fragile X syndrome, Rett syndrome, tuberous sclerosis, neurofibromatosis, phenylketonuria, or congenital rubella
* History of severe birth trauma or traumatic brain injury
* Siblings with autism spectrum disorder
Minimum Eligible Age

18 Months

Maximum Eligible Age

33 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Mental Health (NIMH)

NIH

Sponsor Role collaborator

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rebecca Landa

Director of the Center for Autism and Related Disorders (CARD) and Professor, Johns Hopkins University School of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rebecca Landa, PhD

Role: PRINCIPAL_INVESTIGATOR

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kennedy Krieger Institute

Baltimore, Maryland, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Landa RJ, Holman KC, O'Neill AH, Stuart EA. Intervention targeting development of socially synchronous engagement in toddlers with autism spectrum disorder: a randomized controlled trial. J Child Psychol Psychiatry. 2011 Jan;52(1):13-21. doi: 10.1111/j.1469-7610.2010.02288.x. Epub 2010 Dec 3.

Reference Type DERIVED
PMID: 21126245 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.kennedykrieger.org/kki_cp.jsp?pid=1394

Click here for the Center for Autism and Related Disorders (CARD) at the Kennedy Krieger Institute Web site

http://www.kennedykrieger.org/kki_research.jsp?pid=1800

Click here for the Autism and Neuro-Psychiatric Disorders Research at the Kennedy Krieger Institute Web site

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

U54MH066417

Identifier Type: NIH

Identifier Source: secondary_id

View Link

DDTR BD-DD

Identifier Type: -

Identifier Source: secondary_id

U54MH066417

Identifier Type: NIH

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.